{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T07:36:43Z","timestamp":1780817803876,"version":"3.54.1"},"reference-count":10,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archivos de Bronconeumolog\u00eda"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.arbres.2015.11.015","type":"journal-article","created":{"date-parts":[[2016,2,4]],"date-time":"2016-02-04T00:30:46Z","timestamp":1454545846000},"page":"177-178","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Enfermedad pulmonar obstructiva cr\u00f3nica con eosinofilia, \u00bfun fenotipo emergente?"],"prefix":"10.1016","volume":"52","author":[{"given":"Adolfo","family":"Baloira Villar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abel","family":"Pallar\u00e9s Sanmart\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Supl 1","key":"10.1016\/j.arbres.2015.11.015_bib0055","first-page":"2","article-title":"Gu\u00eda de Pr\u00e1ctica Cl\u00ednica para el Diagn\u00f3stico y Tratamiento de Pacientes con Enfermedad Pulmonar Obstructiva Cr\u00f3nica (EPOC) - Gu\u00eda Espa\u00f1ola de la EPOC (GesEPOC)","volume":"48","year":"2012","journal-title":"Arch Bronconeumol."},{"key":"10.1016\/j.arbres.2015.11.015_bib0060","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1056\/NEJMoa0909883","article-title":"Susceptibility to exacerbation in chronic obstructive pulmonary disease","volume":"363","author":"Hurst","year":"2010","journal-title":"N Engl J Med."},{"key":"10.1016\/j.arbres.2015.11.015_bib0065","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1056\/NEJMra1411863","article-title":"The asthma-COPD overlap symdrome","volume":"373","author":"Postma","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arbres.2015.11.015_bib0070","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.arbres.2011.12.009","article-title":"Consensus document on the overlap phenotype COPD-asthma in COPD","volume":"48","author":"Soler-Catalu\u00f1a","year":"2012","journal-title":"Arch Bronconeumol."},{"key":"10.1016\/j.arbres.2015.11.015_bib0075","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1183\/09031936.00162414","article-title":"Eosinophilic inflammation in COPD: prevalence and clinical characteristics","volume":"44","author":"Singh","year":"2014","journal-title":"Eur Respir J."},{"key":"10.1016\/j.arbres.2015.11.015_bib0080","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1164\/rccm.201408-1458OC","article-title":"Asthma-COPD overlap. Clinical relevance of genomic signatures of type 2 inflammation in chronic obstructive pulmonary disease","volume":"191","author":"Christenson","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.arbres.2015.11.015_bib0085","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S2213-2600(15)00106-X","article-title":"Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: A secondary analysis of date from two parallel randomised controlled trials","volume":"3","author":"Pascoe","year":"2015","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.arbres.2015.11.015_bib0090","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1164\/rccm.201502-0235LE","article-title":"Blood eosinophils: A biomarker of response to extrafine beclomethasone\/formoterol in chronic obstructive pulmonary disease","volume":"192","author":"Siddiqui","year":"2015","journal-title":"Am J Respir Crit Care Med."},{"key":"10.1016\/j.arbres.2015.11.015_bib0095","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.rmed.2015.05.003","article-title":"A post-hoc subgroup analysis of data from a six month clinical trial comparing the efficacy and safety of losmapimod in moderate-severe COPD patients with\u22642% and>2% blood eosinophils","volume":"109","author":"Marks-Konczalik","year":"2015","journal-title":"Respir Med"},{"key":"10.1016\/j.arbres.2015.11.015_bib0100","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1183\/09031936.00146306","article-title":"Eosinophilic airway inflammation and exacerbations of COPD: A randomised controlled trial","volume":"29","author":"Siva","year":"2007","journal-title":"Eur Respir J"}],"container-title":["Archivos de Bronconeumolog\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300289616000119?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300289616000119?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,15]],"date-time":"2018-09-15T19:25:17Z","timestamp":1537039517000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300289616000119"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":10,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["S0300289616000119"],"URL":"https:\/\/doi.org\/10.1016\/j.arbres.2015.11.015","relation":{},"ISSN":["0300-2896"],"issn-type":[{"value":"0300-2896","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enfermedad pulmonar obstructiva cr\u00f3nica con eosinofilia, \u00bfun fenotipo emergente?","name":"articletitle","label":"Article Title"},{"value":"Archivos de Bronconeumolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arbres.2015.11.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 SEPAR. Published by Elsevier Espa\u00f1a, S.L. All rights reserved.","name":"copyright","label":"Copyright"}]}}